Oxford malaria vaccine becomes first to reach WHO efficacy goal
Oxford malaria vaccine becomes first to reach WHO efficacy goal
Indian Express
0 shares
1 views
You might like
Related news coverage
Malaria Vaccine Becomes First To Achieve WHO-Specified 75% Efficacy Goal
Eurasia Review
Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate..
-
New malaria vaccine proves highly effective and COVID shows how quickly it could be deployed
MENAFN.com
-
Africa: Malaria Vaccine Becomes First to Achieve WHO-specified 75% Efficacy Goal
allAfrica.com
-
Malaria vaccine proved 'highly effective' during clinical trials
euronews
-
Potential new malaria vaccine shows promise in Burkina Faso trial
Hindu
Advertisement
More coverage
Oxford Malaria vaccine proves highly effective in Burkina Faso trial
Vaccine developed by scientists at Jenner Institute, Oxford, shows up to 77% efficacy in trial over 12 months
Upworthy